Published in Br J Pharmacol on May 21, 2007
Targeting mitochondria for cancer therapy. Nat Rev Drug Discov (2010) 4.07
Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. J Clin Invest (2009) 1.72
Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest (2011) 1.41
Potential therapeutic benefits of strategies directed to mitochondria. Antioxid Redox Signal (2010) 1.40
Mitochondrial superoxide dismutase SOD2, but not cytosolic SOD1, plays a critical role in protection against glutamate-induced oxidative stress and cell death in HT22 neuronal cells. Free Radic Biol Med (2010) 1.12
Mitochondrial dysfunction in retinal diseases. Curr Eye Res (2011) 1.08
Toxicity of Arsenic (III) on Isolated Liver Mitochondria: A New Mechanistic Approach. Iran J Pharm Res (2013) 1.02
Mitochondrial functions on oocytes and preimplantation embryos. J Zhejiang Univ Sci B (2009) 0.98
The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis. J Biomed Sci (2009) 0.97
Bz-423 superoxide signals apoptosis via selective activation of JNK, Bak, and Bax. Free Radic Biol Med (2008) 0.93
Mitochondria as a target in treatment. Environ Mol Mutagen (2010) 0.92
Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones. Oncogene (2009) 0.92
Nanopreparations for organelle-specific delivery in cancer. Adv Drug Deliv Rev (2013) 0.90
Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases. Curr Pharm Des (2011) 0.90
Asiatic acid, a pentacyclic triterpene in Centella asiatica, attenuates glutamate-induced cognitive deficits in mice and apoptosis in SH-SY5Y cells. Acta Pharmacol Sin (2012) 0.89
Mitochondria and reactive oxygen species: physiology and pathophysiology. Int J Mol Sci (2013) 0.89
Meclizine inhibits mitochondrial respiration through direct targeting of cytosolic phosphoethanolamine metabolism. J Biol Chem (2013) 0.88
Mitochondrial function is involved in regulation of cholesterol efflux to apolipoprotein (apo)A-I from murine RAW 264.7 macrophages. Lipids Health Dis (2012) 0.86
Antioxidant strategies in the management of diabetic neuropathy. Biomed Res Int (2015) 0.83
Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies. Pharmaceuticals (Basel) (2009) 0.83
Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discov (2016) 0.83
Targeted delivery of radioprotective agents to mitochondria. Mol Interv (2008) 0.81
Synthesis and characterization of mitoQ and idebenone analogues as mediators of oxygen consumption in mitochondria. Bioorg Med Chem (2010) 0.80
Isolation of mitochondria from cell cultures by PCT for proteomic analysis. Biotechniques (2008) 0.80
Unique antitumor property of the Mg-Ca-Sr alloys with addition of Zn. Sci Rep (2016) 0.79
High-throughput screening of FDA-approved drugs using oxygen biosensor plates reveals secondary mitofunctional effects. Mitochondrion (2014) 0.79
Phenethyl Isothiocyanate (PEITC) Inhibits the Growth of Human Oral Squamous Carcinoma HSC-3 Cells through G(0)/G(1) Phase Arrest and Mitochondria-Mediated Apoptotic Cell Death. Evid Based Complement Alternat Med (2012) 0.77
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future. Curr Top Med Chem (2016) 0.77
Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. Chem Rev (2017) 0.76
MitoBlue: a nontoxic and photostable blue-emitting dye that selectively labels functional mitochondria. ACS Chem Biol (2014) 0.76
Integrating Enzymatic Self-Assembly and Mitochondria Targeting for Selectively Killing Cancer Cells without Acquired Drug Resistance. J Am Chem Soc (2016) 0.76
Synthesis of triphenylphosphonium vitamin E derivatives as mitochondria-targeted antioxidants. Tetrahedron (2015) 0.76
The Roots of Atractylodes macrocephala Koidzumi Enhanced Glucose and Lipid Metabolism in C2C12 Myotubes via Mitochondrial Regulation. Evid Based Complement Alternat Med (2015) 0.75
3'-Daidzein sulfonate sodium improves mitochondrial functions after cerebral ischemia/reperfusion injury. Neural Regen Res (2017) 0.75
Investigation of cyanine dyes for in vivo optical imaging of altered mitochondrial membrane potential in tumors. Cancer Med (2014) 0.75
Inhibition of stress-inducible HSP70 impairs mitochondrial proteostasis and function. Oncotarget (2017) 0.75
Prospects for therapeutic mitochondrial transplantation. Mitochondrion (2017) 0.75
Optimization of Mitochondrial Isolation Techniques for Intraspinal Transplantation Procedures. J Neurosci Methods (2017) 0.75
Mitochondria and apoptosis. Science (1998) 23.41
Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell (1996) 16.73
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
The pathobiology of diabetic complications: a unifying mechanism. Diabetes (2005) 14.96
Hydroperoxide metabolism in mammalian organs. Physiol Rev (1979) 14.13
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature (2000) 12.33
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science (1988) 11.76
Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature (2005) 11.22
Mitochondrial dysfunction and type 2 diabetes. Science (2005) 10.25
Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature (1999) 8.70
Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature (2005) 8.51
The mitochondrial permeability transition pore and its role in cell death. Biochem J (1999) 7.72
OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell (2006) 7.72
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science (2004) 7.63
Biogenesis of mitochondria. Annu Rev Cell Biol (1988) 6.96
Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab (2005) 6.85
Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med (2000) 5.90
The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature (2004) 5.85
Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell (2006) 5.51
Superoxide activates mitochondrial uncoupling proteins. Nature (2002) 5.43
Role of Bax and Bak in mitochondrial morphogenesis. Nature (2006) 5.25
A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science (2004) 4.95
Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A (1987) 4.87
Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol (2001) 4.80
Mitochondrial membrane potential in living cells. Annu Rev Cell Biol (1988) 4.73
Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol (2005) 4.67
Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem (2005) 4.29
DRP-1-mediated mitochondrial fragmentation during EGL-1-induced cell death in C. elegans. Nature (2005) 3.99
Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. Cardiovasc Res (2004) 3.96
Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem (2004) 3.44
Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med (2002) 3.31
The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J (2006) 3.26
Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem (2004) 3.14
Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest (2003) 2.95
The internal structure of mitochondria. Trends Biochem Sci (2000) 2.94
Transfected aequorin in the measurement of cytosolic Ca2+ concentration ([Ca2+]c). A critical evaluation. J Biol Chem (1995) 2.91
Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci (2001) 2.89
A leader peptide is sufficient to direct mitochondrial import of a chimeric protein. EMBO J (1985) 2.78
Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci U S A (1992) 2.72
Diabetes and obesity: the twin epidemics. Nat Med (2006) 2.72
Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem (1997) 2.64
New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res (2004) 2.63
Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res (1984) 2.44
The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site. Arch Biochem Biophys (1979) 2.44
Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). J Biol Chem (2004) 2.42
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst (1999) 2.41
Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng (2006) 2.39
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest (2003) 2.35
Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J (2005) 2.33
Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. J Biol Chem (1998) 2.32
Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur J Biochem (1998) 2.32
Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion (2005) 2.24
bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res (1992) 2.15
Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2006) 2.08
Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science (1999) 2.06
High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes (2001) 2.02
Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem J (1987) 1.92
Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem J (1998) 1.92
Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta (1998) 1.91
Drug targeting. Eur J Pharm Sci (2000) 1.91
Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol (1999) 1.87
Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol (2000) 1.86
Properties of the permeability transition in VDAC1(-/-) mitochondria. Biochim Biophys Acta (2006) 1.74
Mitochondrial intermembrane junctional complexes and their involvement in cell death. Biochimie (2002) 1.71
Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J (2003) 1.70
Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Biophys Acta (2005) 1.68
Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem (2005) 1.65
Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J (2006) 1.65
Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta (1998) 1.64
A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J Biol Chem (2006) 1.61
The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res (2004) 1.58
The SERCA pump as a therapeutic target: making a "smart bomb" for prostate cancer. Cancer Biol Ther (2005) 1.56
Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet (1997) 1.53
Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol (1997) 1.48
Multiple Q-cycle bypass reactions at the Qo site of the cytochrome bc1 complex. Biochemistry (2002) 1.47
Chemiosmotic hypothesis of oxidative phosphorylation. Nature (1967) 1.47
Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene (2000) 1.45
Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes. Diabetologia (2001) 1.39
The emerging functions of UCP2 in health, disease, and therapeutics. Antioxid Redox Signal (2006) 1.36
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity. J Clin Oncol (2005) 1.33
Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in Bcl-2 overexpressing HL60 cells. FASEB J (2002) 1.30
Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J (2006) 1.24
PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp Cell Res (1998) 1.23
The relationship between oxygen radical generation and impairment of myocardial energy metabolism following post-ischemic reperfusion. J Mol Cell Cardiol (1991) 1.22
MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. Cancer Res (1996) 1.21
Mitochondrial electron transport can become a significant source of oxidative injury in cardiomyocytes. J Mol Cell Cardiol (1997) 1.21
The role of the mitochondrial permeability transition in cell death. Mitochondrion (2006) 1.20
UCP2 and UCP3 in muscle controlling body metabolism. J Exp Biol (2002) 1.14
Medicine. Targeting apoptotic pathways in cancer cells. Science (2004) 1.13
Bax and the mitochondrial permeability transition cooperate in the release of cytochrome c during endoplasmic reticulum-stress-induced apoptosis. Cell Death Differ (2006) 1.12
Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res (1995) 1.11
The emerging pandemic of obesity and diabetes: are we doing enough to prevent a disaster? Int J Clin Pract (2006) 1.10
The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition. Oncogene (1998) 1.09
Iron and Friedreich ataxia. J Neural Transm Suppl (2006) 1.06
A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax. Gene Ther (2000) 1.05
Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke. CNS Drugs (2004) 1.04
Mitochondrial permeability: dual role for the ADP/ATP translocator? Nature (2004) 1.04
The ubiquinone-binding site of the Saccharomyces cerevisiae succinate-ubiquinone oxidoreductase is a source of superoxide. J Biol Chem (2003) 1.03
Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic. Insights into the interaction of ebselen with mitochondria. J Biol Chem (2005) 1.02